Form 8-K - Current report:
SEC Accession No. 0001558370-25-006594
Filing Date
2025-05-07
Accepted
2025-05-07 06:30:11
Documents
15
Period of Report
2025-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tech-20250507x8k.htm   iXBRL 8-K 37207
2 EX-99.1 tech-20250507xex99d1.htm EX-99.1 631326
3 EX-99.2 tech-20250507xex99d2.htm EX-99.2 22146
  Complete submission text file 0001558370-25-006594.txt   849594

Data Files

Seq Description Document Type Size
4 EX-101.SCH tech-20250507.xsd EX-101.SCH 3395
5 EX-101.LAB tech-20250507_lab.xml EX-101.LAB 15264
6 EX-101.PRE tech-20250507_pre.xml EX-101.PRE 10903
17 EXTRACTED XBRL INSTANCE DOCUMENT tech-20250507x8k_htm.xml XML 4603
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 25919158
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)